Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Compared with current practices, routine screening could prevent 23,000 deaths from liver disease.
Low-barrier care and access to multiple services in one place can improve outcomes for people experiencing homelessness or unstable housing.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
Positive diagnostic tests and drug prescriptions dropped 40% in July 2020 compared with earlier years.
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
The protein subunit vaccine provides 100% protection against moderate or severe disease, hospitalization and death.
Alzheimer’s advocates laud the approval of Aduhelm, but experts raise questions about its effectiveness and cost.
While the number of breakthrough cases is not trivial, it represents a miniscule proportion of people who are fully vaccinated.
The Epclusa and Mavyret combination pills are now indicated for kids as young as age 3.
Assessing patient-reported outcomes can support treatment for hard-to-reach populations.
The American College of Obstetricians and Gynecologists advises screening during each pregnancy.
People with NAFLD have an elevated risk of cancer, largely due to high liver cancer incidence.
Based on surveys conducted in 2015 and 2018, the number appears to have nearly tripled in San Francisco.
An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.
Molnupiravir, first developed for hepatitis C, might be able to prevent or treat COVID-19 outside of a clinical setting.
Among people treated for hepatitis C, diabetes and chronic kidney disease were both linked to a higher risk of cardiovascular death.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.